Financials
Financial year 2025
ACLOT PHARMA from Nivelles, company number BE0456857330, closed financial year 2025 with a result of € 107 after tax. For that financial year ACLOT PHARMA recorded a gross margin of € 332,643 and equity of € 126,895. Compared with financial year 2024, the result moved from € 46,977 to € 107. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 27, 2026.
€ 126,895
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 107
▼ € 46,870 vs 2024
Profit after tax over the fiscal year.
€ 176,082
▲ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 108,295.
People and assets in 2025
€ 197,769
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,314
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 396,667
▼ 9% vs 2024
€ 40,000 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 156,645
▲ € 121,197 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,720
▼ 2% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 313,802 | € 303,698 | € 361,806 | € 332,643 | ▼ 8% |
| Profit after taxes | € 25,438 | € -6,721 | € 46,977 | € 107 | ▼ € 46,870 |
| Equity | € 126,531 | € 119,811 | € 126,788 | € 126,895 | |
| Total debts | € 1,318,898 | € 1,279,724 | € 1,256,505 | € 1,097,126 | ▼ 13% |
| Cash | € 86,511 | € 98,581 | € 171,054 | € 176,082 | ▲ 3% |
| Land & buildings | € 401,435 | € 385,324 | € 369,213 | € 349,090 | ▼ 5% |
| Retained profit | € 107,931 | € 101,211 | € 108,188 | € 108,295 | |
| Dividend | € 0 | € 0 | € 40,000 | € 0 | ▼ 100% |
| Bank debt | € 516,667 | € 476,667 | € 436,667 | € 396,667 | ▼ 9% |
| Balance sheet total | € 1,445,429 | € 1,399,535 | € 1,383,293 | € 1,224,021 | ▼ 12% |
| Employees (FTE) | - | 2.4 | 2.4 | - |
Key figures of ACLOT PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ACLOT PHARMA?
What happened at ACLOT PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 107 (▼ € 46,870 vs 2024). filed late Source: NBB ↗
- New establishment in Nivelles. KBO
- Start of the company according to the CBE. KBO
In short
From € 25,438 profit in 2022 to € 107 profit in 2025.
Paid € 2,383 in corporate taxes since 2022.
Best year ever: 2024, with € 46,977 profit.
On average € 150,800 of value added per employee in 2024.
Establishments
Establishment units
Physical locations of this company
Rue du Paradis 101
1400 Nivelles
Rue Sainte-Anne 8
1400 Nivelles
Active since 29 February 1996
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0456.857.330
- VAT number
- BE 0456.857.330
- Registered office
- Rue du Paradis 101, 1400 Nivelles
- Names & denominations
- ACLOT PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 1995
- Peppol
- Active · Active since 23 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers